Welcome to CDC Stacks | Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors - 28119 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
Filetype[PDF - 312.56 KB]


Details:
No Related Documents.
You May Also Like:
  1. Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
    Personal Author:
    Collins, Matthew H.; McGowan, Eileen; Jadi, Ramesh; Young, Ellen; Lopez, Cesar A.; Baric, Ralph S.; Lazear, Helen M.; de Silva, Aravinda M.;
    Published:
    May 2017
    Source:
    Emerg Infect Dis. 23(5):773-781.
    Description:
    Cross-reactive antibodies elicited by dengue virus (DENV) infection might affect Zika virus infection and confound serologic tests. Recent data demonstrate neutralization of Zika virus by monoclonal antibodies or human serum collected early after DEN...
    File Type:
    Filetype[PDF - 1.72 MB]
  2. Hepatitis E Virus Antibodies in Blood Donors, France
    Personal Author:
    Mansuy, Jean-Michel; Bendall, Richard; Legrand-Abravanel, Florence; Sauné, Karine; Miédouge, Marcel; Ellis, Vic; Rech, Henri; Destruel, François; Kamar, Nassim; Dalton, Harry R.; Izopet, Jacques;
    Published:
    Dec 2011
    Source:
    Emerg Infect Dis. 17(12):2309-2312.
    Description:
    Using a validated sensitive assay, we found hepatitis E virus (HEV) IgG in 52.5% of voluntary blood donors in southwestern France. This finding suggests HEV is highly endemic to this region. The high HEV prevalence may reflect local dietary practices...
    File Type:
    Filetype[PDF - 219.39 KB]
  3. Neutralizing Antibodies after Infection with Dengue 1 Virus
    Personal Author:
    Guzman, Maria G.; Alvarez, Mayling; Rodriguez-Roche, Rosmari; Bernardo, Lídice; Montes, Tibaire; Vazquez, Susana; Morier, Luis; Alvarez, Angel; Gould, Ernest A; Kourí, Gustavo; Halstead, Scott B;
    Published:
    Feb 2007
    Source:
    Emerg Infect Dis. 13(2):282-286.
    Description:
    Severity of disease is markedly increased when infection with dengue virus type 2 (DENV-2) follows infection with DENV-1 at an interval of 20 years. Studies have shown that heterologous neutralizing antibody titers are inversely correlated with sever...
    File Type:
    Filetype[PDF - 74.80 KB]
  4. Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel
    Published:
    Jul 2009
    Source:
    Emerg Infect Dis. 15(7):1116-1118.
    Description:
    The prevalence of infection with human T-cell lymphotropic virus type 1 (HTLV-1) in blood donors from Israel is 1 infection/100,000 persons. In donors originating from Eastern Europe, the Middle East, and Latin America, prevalences are 7.7, 14.6, and...
    File Type:
    Filetype[PDF - 424.43 KB]
  5. West Nile Virus Infection in Plasma of Blood and Plasma Donors, United States
    Personal Author:
    Planitzer, Christina B.; Modrof, Jens; Yu, Mei-ying W.; Kreil, Thomas R.;
    Published:
    Oct 2009
    Source:
    Emerg Infect Dis. 15(10):1668-1670.
    Description:
    This study investigated the association of ongoing West Nile virus (WNV) infections with neutralizing antibody titers in US plasma-derived intravenous immune globulin released during 2003-2008. Titers correlated closely with the prevalence of past WN...
    File Type:
    Filetype[PDF - 519.97 KB]